Inicio › Colitis ulcerativa › Carolina del Norte
Ensayos clínicos de Colitis ulcerativa en Carolina del Norte
24 estudios sobre Colitis ulcerativa buscan participantes en Carolina del Norte.
Ciudades en Carolina del Norte
- Durham11 estudios
- Charlotte7 estudios
- Fayetteville4 estudios
- Wilmington4 estudios
- Raleigh3 estudios
- Greenville3 estudios
Texto oficial del estudio (inglés)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Digestive Health Partners /ID# 280490, Asheville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07697456A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- 040, Chapel Hill
- Site 041, Durham
- Site 016, Winston-Salem
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07012395Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Raleigh
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT06619990A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Monroe Biomedical Research, Monroe
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Coastal Research Institute - Fayetteville, Fayetteville
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Carolina Digestive Diseases and Endoscopy Center, Greenville
- Wilmington Health, PLLC, Wilmington
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Digestive Health Partners, Asheville
- University of North Carolina, Chapel Hill
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Cross Creek Medical Clinic - Site Number: 8400057, Fayetteville
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07185009A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Charlotte Gastroenterology and Hepatology, P.L.L.C, Charlotte
- Carolina Digestive Diseases, Greenville
- Piedmont Healthcare, Statesville
- y 1 más
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT06581328Confirmatory Clinical Study in Active Ulcerative Colitis
- Cross Creek Medical Clinic, Fayetteville
- Peters Medical Research, High Point
ReclutandoFase 2
Edades de 16 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07296315A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
ReclutandoFase 4
Edades de 18 en adelante · Mujeres · Actualizado el 28 ago 2026 · NCT07654751A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Atrium Health Gastroenterology and Hepatology, Charlotte
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 21 ago 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- UNC Hospitals, The University of North Carolina at Chapel Hill - Site Number: 8400074, Chapel Hill
- OnSite Clinical Solutions - Site Number: 8400051, Charlotte
- Duke University Medical Center - Site Number: 8400093, Durham
- y 3 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 20 ago 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- UNC Chapel Hill, Chapel Hill
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of North Carolina, Chapel Hill
- Atrium Health Center for Gastroenterology and Surgery, Charlotte
- Wake Forest School of Medicine, Winston-Salem
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07237516A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 jul 2026 · NCT06598943An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill
- OnSite Clinical Solutions, LLC, Charlotte
ReclutandoEstudio observacional
Edades de 18 a 64 · Todos los sexos · Actualizado el 9 jul 2026 · NCT06398626A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
- PPD Virtual - PPD - US, Wilmington
ReclutandoEstudio observacional
Todas las edades · Mujeres · Actualizado el 15 jun 2026 · NCT05953402A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400002, Chapel Hill
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 23 abr 2026 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, High Point
- Mirador Therapeutics Selected Site, Raleigh
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 010, Greenville
ReclutandoFase 4
Edades de 5 a 17 · Todos los sexos · Actualizado el 16 sept 2025 · NCT04314375Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- University of North Carolina, Chapel Hill
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 may 2025 · NCT06750731IBD Pregnancy Registry
- PPD, Wilmington
ReclutandoEstudio observacional
Edades de 18 a 50 · Mujeres · Actualizado el 4 abr 2025 · NCT06910553De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.